Gabelli Equity Trust (GAB) 5.81 $GAB Fitch Affirms

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gabelli Equity Trust (GAB) 5.81 $GAB

Fitch Affirms Gabelli Fund Auction Preferred Ratings at 'AA'
BusinessWire - Tue Jun 21, 3:50PM CDT
Fitch Ratings has affirmed the 'AA' ratings assigned to the outstanding auction rate preferred shares of the four Gabelli equity closed-end funds listed below. All funds are managed by Gabelli Funds, LLC as investment adviser.
GGT: 7.75 (-0.03), GAB: 5.81 (+0.03), GBL: 30.72 (-0.07), GDV: 19.77 (-0.03), GUT: 6.63 (+0.02)

Gabelli Equity Trust Reaffirms Its 10% Distribution Policy and Declares Second Quarter Distribution of $0.15 Per Share
BusinessWire - Thu May 19, 8:14AM CDT
The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the "Fund" reaffirmed its 10% distribution policy and declared a $0.15 per share cash distribution payable on June 23, 2016 to common stock shareholders of record on June 16, 2016.
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

Gabelli Equity Trust Announces the Offering of $80 Million of 5.45% Series J Cumulative Preferred Stock
BusinessWire - Mon Mar 28, 3:35PM CDT
The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the "Fund" is pleased to announce the completion of an offering of 3.2 million shares of 5.45% Series J Cumulative Preferred Stock ("Series J Preferred" valued at $80 million. The offering is expected to close on Thursday, March 31, 2016, subject to customary closing conditions.
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

Gabelli Equity Trust Down 14.4% Since SmarTrend Downtrend Call (GAB)
Comtex SmarTrend(R) - Tue Jan 05, 11:58AM CST
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 5 months, Gabelli Equity Trust has returned 14.45% as of today's recent price of $5.21.
GAB: 5.81 (+0.03)

Gabelli Equity Trust Shares Down 12.2% Since SmarTrend's Sell Call (GAB)
Comtex SmarTrend(R) - Thu Dec 24, 5:24PM CST
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 5 months, Gabelli Equity Trust has returned 12.15% as of today's recent price of $5.35.
GAB: 5.81 (+0.03)

Shares of GAB Down 13.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Dec 17, 10:19AM CST
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 5 months, Gabelli Equity Trust has returned 13.59% as of today's recent price of $5.26.
GAB: 5.81 (+0.03)

Gabelli Equity Trust Reaffirms Its 10% Distribution Policy and Declares Fourth Quarter Distribution of $0.19 Per Share
BusinessWire - Thu Nov 19, 3:05PM CST
The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the "Fund" reaffirmed and satisfied its 10% distribution policy by declaring a $0.19 per share cash distribution payable on December 18, 2015 to common stock shareholders of record on December 11, 2015. With this fourth quarter distribution, the total distributions from the Fund for 2015 would equate to $0.64 per share. The Fund paid distributions of $0.15 per share in each of the first, second, and third quarters of 2015.
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

Gabelli Equity Trust Has Returned 10.7% Since SmarTrend Recommendation (GAB)
Comtex SmarTrend(R) - Mon Nov 16, 10:10AM CST
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 4 months, Gabelli Equity Trust has returned 10.67% as of today's recent price of $5.44.
GAB: 5.81 (+0.03)

7.9% Return Seen to Date on SmarTrend Gabelli Equity Trust Call (GAB)
Comtex SmarTrend(R) - Thu Oct 22, 9:42AM CDT
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 3 months, Gabelli Equity Trust has returned 7.88% as of today's recent price of $5.61.
GAB: 5.81 (+0.03)

Gabelli Equity Trust Has Returned 7.8% Since SmarTrend Recommendation (GAB)
Comtex SmarTrend(R) - Fri Oct 09, 10:25AM CDT
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 2 months, Gabelli Equity Trust has returned 7.78% as of today's recent price of $5.62.
GAB: 5.81 (+0.03)

11.8% Return Seen to Date on SmarTrend Gabelli Equity Trust Call (GAB)
Comtex SmarTrend(R) - Tue Sep 15, 10:14AM CDT
SmarTrend identified a Downtrend for Gabelli Equity Trust (NYSE:GAB) on July 27th, 2015 at $6.09. In approximately 2 months, Gabelli Equity Trust has returned 11.82% as of today's recent price of $5.37.
GAB: 5.81 (+0.03)

Gabelli Equity Trust Reaffirms Its 10% Distribution Policy and Declares Third Quarter Distribution of $0.15 Per Share
BusinessWire - Thu Aug 20, 8:26AM CDT
The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the "Fund" reaffirmed its 10% distribution policy and declared a $0.15 per share cash distribution payable on September 23, 2015 to common stock shareholders of record on September 16, 2015.
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

Gabelli Equity Trust Reaffirms Its 10% Distribution Policy and Declares First Quarter Distribution of $0.15 Per Share
BusinessWire - Tue Feb 17, 3:45PM CST
The Board of Directors of The Gabelli Equity Trust Inc. (NYSE:GAB) (the "Fund" reaffirmed its 10% distribution policy and declared a $0.15 per share cash distribution payable on March 24, 2015 to common stock shareholders of record on March 17, 2015.
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

GAMCO Investors, Inc. Reports Fourth Quarter & Full Year Results
BusinessWire - Tue Feb 03, 4:30PM CST
--Second Best Fourth Quarter Earnings of $1.13 per diluted share
GAB: 5.81 (+0.03), GBL: 30.72 (-0.07)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading